Reusch V M, Panos C
J Bacteriol. 1976 Apr;126(1):300-11. doi: 10.1128/jb.126.1.300-311.1976.
Membrane preparations obtained from a stabilized L-form of Streptococcus pyogenes are incapable of synthesizing peptidoglycan from uridine-5'-diphospho-N-acetyl-D-muramyl-L-Ala-D-iso-Glu-L-Lys-D-Ala-D-Ala and uridine-5'-diphospho-N-acetyl-D-glucosamine, in contrast with similar preparations from the parental streptococcus. Furthermore, 50-fold higher levels of lipid intermediates which serve as membrane-bound substrates for peptidoglycan synthesis are synthesized in reaction mixtures containing streptococcal membranes than with similar preparations from the L-form. These observations suggest that the inability of this stabilized L-form to form a cell wall in vivo lies, at least in part, in its failure to synthesize significant quantities of the lipid substrates for peptidoglycan synthesis.
与亲本链球菌的类似制剂相比,从化脓性链球菌的稳定L型获得的膜制剂不能从尿苷-5'-二磷酸-N-乙酰-D-胞壁酰-L-丙氨酸-D-异谷氨酰胺-L-赖氨酸-D-丙氨酸-D-丙氨酸和尿苷-5'-二磷酸-N-乙酰-D-葡萄糖胺合成肽聚糖。此外,与L型的类似制剂相比,在含有链球菌膜的反应混合物中合成的脂质中间体水平高出50倍,这些脂质中间体作为肽聚糖合成的膜结合底物。这些观察结果表明,这种稳定的L型在体内无法形成细胞壁,至少部分原因在于它无法合成大量用于肽聚糖合成的脂质底物。